Farinelli breathing (FB) exercise is a typical breathing exercise used by singers. This study aimed to compare effects of FB exercise and diaphragmatic breathing (DB) exercise on respiratory function and symptoms in patients with chronic obstructive pulmonary disease (COPD).
Sixteen patients aged 51–80 years with mild or moderate COPD were recruited for this study. They were divided into two groups: DB group (n=8) and FB group (n=8). Both groups received complete breathing exercise training five times per week for 8 weeks. Their respiratory functions, COPD symptoms, cytokine levels, and oxidative stress variables were analyzed during pre- and post-tests. Dependent variables were compared between pre- and post-tests using paired t-tests. An independent t-test was used to compare variables between the groups. Differences were considered significant at p<0.05.
The maximal expiratory pressure (MEP), maximum oxygen consumption (VO2max), and COPD Assessment Test (CAT) scores changed significantly in the DB group after the 8-week intervention compared to those at pre-test, whereas force vital capacity, forced expiratory volume in the first second, maximum voluntary ventilation, maximal inspiratory pressure (MIP), MEP, VO2max, CAT score, tumor necrosis factor-α, and malondialdehyde level changed significantly in the FB group at post-test compared to those at pre-test. Moreover, both MIP and MEP in the FB group were significantly higher than those in the DB group.
FB exercise improved respiratory functions and COPD symptoms of patients with COPD. It might be an alternative breathing exercise in pulmonary rehabilitation programs for patients with COPD.
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally. COPD is a common, treatable, and preventable disease characterized by airflow limitation and persistent respiratory system infections resulting from exposure to noxious gases and particles [
Breathing exercises such as low-intensity aerobic exercise can improve exercise tolerance, increase respiratory muscle strength and endurance, correct abnormal chest and abdominal movements, and diminish hyperinflation [
This study utilized a pre-test/post-test interventional research design. It was approved by the Institutional Review Board of the Royal Thai Army Medical Department, Thailand (Study Code: IRBRTA 1347/2562). This study was registered as a clinical trial with clinical trials.gov (no. NCT04869033). The sample size of participants was calculated using the G*Power program (3.1.9.2) with an alpha error of 0.05 and a power of 0.80. A minimum of six participants in each group were required for this study. Nineteen patients with COPD were recruited from Phramongkutklao Hospital for this study. All participants gave written informed consent prior to participation in the study. These patients were assigned to FB and DB groups using random allocation by investigators and stratified by sex (male and female), age (51–60, 61–70, and 71–80 years old), and COPD severity (mild and moderate). The severity was determined after repeated pulmonary function tests based on the predicted forced expiratory volume in the first second (FEV1%) and FEV1/force vital capacity (FVC) ratio according to the 2021 Global Initiative for Chronic Obstructive Lung Disease. Inclusion criteria were as follows: (1) patients with COPD who were treated at Phramongkutklao Hospital; (2) having a history of smoking; (3) predicted FEV1 of more than 50% after bronchodilator; (4) no change in medication whitin 4 weeks preceding the study; (5) no history of acute exacerbations within 4 weeks befor this study; and (6) no history of cardiac disease. Exclusion criteria were as follows: (1) recurrent acute exacerbations; (2) inability to participate in at least 80% of the training program (≤32 sessions of 40 sessions); (3) unwillingness to continue performing the exercise.
Participants were contacted. They underwent a 2-hour orientation, which included assessment training, after their main healthcare practitioner granted them medical clearance to participate (after blood collecting, physiological characteristics, pulmonary function, respiratory muscle strength, 6-MWD, and COPD questionnaires) in the intervention procedures (breathing exercises). Data were collected in a confidentiality and privacy room of the hospital. Health history, COPD questionnaires (including the modified Medical Research Council Dyspnea Scale [mMRC], and COPD Assessment Test [CAT] were obtained or performed through interviews on the pre-experimental day. Characteristics such as age, weight, body mass index (BMI), blood pressure, percentage of body fat, and SpO2 were recorded. Blood was collected into sterile ethylenediaminetetraacetic acid (EDTA) tubes from the cubital vein by a nurse at Phramongkutklao Hospital and analyzed by a medical technologist. EDTA blood was centrifuged at 3,000 rpm for 10 minutes to obtain plasma. All plasma samples were stored at –80°C before their use in different assays. Pulmonary function was assessed repeatedly before evaluating respiratory muscle strength and the 6-MWD. All participants were randomly assigned to the DB or FB group. They continued to receive their regular medication.
Following the initial examination, participants were given a breathing exercise manual notebook that contained program instructions and an activity diary to evaluate program adherence. Each participant was given a personalized home breathing exercise regimen (5 days per week for 8 weeks), which was closely monitored by researchers. Participants were monitored during breathing exercise sessions. They continued to take their prescribed bronchodilator medications. Furthermore, researchers called all participants twice a week to correct the performance of the breathing exercise as needed, to inquire about any barriers that participants encountered during sessions, and to verify the correct performance of the breathing exercise.
This study was designed with two different types of breathing exercises: DB and FB. These groups were differentiated by the route and time in seconds of inhalation, suspension, and exhalation. Both groups were instructed to practice in a seated position on a chair with back support, starting with normal breathing (NB) for 1 minute, followed by a different breathing pattern. In the DB group, patients inhaled through the nose and exhaled through the mouth. After 1 minute of NB, patients inhaled for 2 seconds and exhaled for 2 seconds through the nasal airway. This pattern was continued for 4 minutes. Patients then returned to NB for 1 minute. One minute of NB and 4 minutes of DB were considered as one set. Participants were asked to perform six sets per day, 5 days per week (Monday–Friday) for weeks 1–4. For weeks 5–8, they were aksed to perform eight sets per day, 5 days per week.
In the FB group, patients inhaled through the nose, held their breath, and exhaled using pursed lips. After 1 minute of NB, patients followed the following set of instructions: (1) inhaled for 2 seconds, suspended for 2 seconds, exhaled for 2 seconds; (2) inhaled for 3 seconds, suspended for 3 seconds, exhaled for 3 seconds; (3) inhaled for 4 seconds, suspended for 4 seconds, exhaled for 4 seconds; (4) inhaled for 5 seconds, suspended for 5 seconds, exhaled for 5 seconds; and (5) inhaled for 6 seconds, suspended for 6 seconds, exhaled for 6 seconds. This cycle lasted for 1 minute. It was repeated a total of four times. One minute of NB and 4 minutes of FB were considered as one set. Participants were asked to perform six sets per day, 5 days per week (Monday–Friday) for weeks 1–4. For weeks 5–8, they were asked to perform eight sets per day, 5 days per week.
Pulmonary function and breathing pattern were assessed using the predicted value and liters of FVC, vital capacity (VC), and the maximum voluntary ventilation (MVV) maneuver analyzed with a computerized spirometer (MIR Spirobank G, Rome, Italy) according to guidelines of the American Thoracic Society pulmonary function test. Participants were asked to wear a nose clip while sitting on a chair. The researcher gave participants a step-by-step protocol to prevent incorrect maneuvers. For FVC maneuver, three cycles of slow NB were performed before demonstrating forced inspiration and expiration and returning to NB. For the VC maneuver, NB inhalation and exhalation were performed until the signal of the device sounded, followed by deep and slow inhalation and exhalation. For the MVV maneuver, participants were asked to inhale and exhale quickly and forcefully for 10 seconds.
Respiratory muscle strength was assessed by measuring the MIP and MEP in a seated position using a portable handheld mouth pressure meter (i.e., MicroRPM) with a nose clip. For the MIP measurement, participants were asked to exhale until they felt no air remaining in their lungs (starting with the functional residual capacity point). They then held the device on their mouth and inhaled forcefully for 1–2 seconds. For the MEP measurement, participants were asked to inhale until their lungs were completely filled with air (starting with the total lung capacity [TLC] point). They then kept the device on their mouth and exhaled forcefully for 1–2 seconds.
Aerobic capacity was assessed using the 6-MWD following the guidelines of the 2002 American Thoracic Society. A modified 25 m straight walking test with turning points was performed on the 4th floor next to the Critical Pulmonary Division. Participants were asked to wear comfortable clothes and shoes during the test. Their vital signs (e.g., resting heart rate and blood pressure) were evaluated before and after the test. Participants were asked to walk at a comfortable pace for 6 minutes under the supervision of a nurse. They were permitted to terminate and rest during the test if they sensed heavy dyspnea. Researchers collected the data and calculated the maximum oxygen consumption (VO2max) using the following formula:
VO2max (mL/kg/min)=[0.02×distance (m)]–[0.191×age (year)]–[0.07×weight (kg)]+[0.09×height (cm)]+[0.26×heart rate (bpm)]×systolic blood pressure (mm Hg)×(10–3)+245.
Effects of exercise on COPD symptoms were assessed using mMRC and CAT scores. The mMRC is a questionnaire used to evaluate the level of disability in the daily life of patients with COPD [
All data were statistically analyzed for their normal distribution using the Shapiro–Wilk test before calculating the mean and standard deviation (SD). Characteristic data, pulmonary function, respiratory muscle strength, inflammatory cytokines, oxidative stress, aerobic capacity, and effects on COPD symptoms were analyzed using independent t-tests to compare groups. A paired t-test was used to compare results before and after breathing exercises. All statistical analyses were performed using the SPSS software program version 17.0 (SPSS Inc., Chicago, IL, USA) for Windows. Tests were considered to be significant when p-value was less than 0.05.
Eligible participants were allocated into two groups (
No variable was significantly different at baseline between the two groups (all p>0.05). Data are expressed as mean and SD (
The FB group showed significant changes in FVC (p=0.026), FEV1 (p=0.012), and MVV maneuver (p<0.001) after the exercise. However, there was no significant difference in pulmonary function between the two groups (
In the DB group, only MEP was changed significantly (p=0.013) after the exercise. In the FB group, both MIP (p<0.001) and MEP (p<0.001) were changed significantly. Both MIP and MEP were significantly higher in the FB group than those in the DB group when they were compared at post-test (p=0.016 and p= 0.039, respectively). Moreover, after 8 weeks of breathing exercises, 6-MWD (p=0.005 and p=0.002, respectively) and VO2max (p=0.010 and p=0.035, respectively) were increased significantly in DB and FB groups when compared to those at pre-test, although they were not significantly different between the two groups (
There was no statistical change in inflammatory cytokine or oxidative stress in the DB group after the exercise. However, TNF-α (p=0.027) and malondialdehyde (MDA) levels (p=0.015) were significantly reduced in the FB group after the exercise, although they were not significantly different between the two groups at post-test (
Regarding effects of exercise on COPD symptoms, both groups showed significantly reduced CAT scores (p=0.017 and p=0.005), although there was no significant difference in any symptom score between the two groups at post-test (
The main finding of this study was that respiratory functions and COPD symptoms in patients with stable (stage I and stage II) COPD were improved, which was a novel finding. Respiratory functions and dyspnea symptoms are known to worsen in patients with COPD. Two main pathophysiological characteristics, chronic bronchitis and emphysema, can lead to excessive sputum production and narrowing of airways, resulting in an insufficient capacity for gas exchange [
The better the respiratory function of COPD patients, the greater the health benefits. Immune responses play an important role in respiratory function. ROS can change biological molecules, signaling pathways, and activities of antioxidant molecules. Elevated cytokines and oxidative stress are known to be implicated in the pathogenesis of COPD. The repetitive breathing cycle of FB can result in an alteration in the immune response of respiratory muscles by downregulating inflammatory cytokines and decreasing TNF-α production from macrophages [
Dyspnea is an important respiratory symptom present in COPD. It is caused by decreased O2 levels in the aorta. Increased H+ and CO2 levels in arteries can cause respiratory discomfort and breathlessness, triggering the medulla oblongata to initiate inspiratory neural drive in lung receptors and respiratory muscles to instruct breathing [
The aim of the study was to compare effects of FB and DB exercises on respiratory function and symptoms in patients with COPD. The following limitations of this study should be considered when interpreting results of this study. First, the number of enrolled participants was small. Future research enrolling more patients with COPD having varying severity is needed to validate possible applications of these findings in patients using combined medication and perform comparisons with other breathing exercises. Second, we discovered that patients with COPD were overweight (the average BMI of participants was above 25 kg/m2) with decent lung function, different from prior studies [
In conclusion, for COPD patients, the FB exercise can open up airways sufficiently enough to allow more air to pass through and aid in the control of shortness of breath. FB exercise is a quick and easy technique that can reduce a patient’s breathing rate, making each breath more efficient. Although this breathing technique is somewhat complex, if practiced on a regular basis, it may become habitual. This exercise can enhance pulmonary function, respiratory muscle strength, aerobic capacity, and reduce inflammatory cytokines, oxidative stress, and COPD symptoms. Healthcare practitioners such as nurses, physicians, and exercise therapists play important roles in promoting this beneficial exercise as a useful alternative for COPD patients by incorporating it into their advice, patient manuals, and practical guidelines for improving health status and quality of life.
Conceptualization: Ittinirundorn S, Wongsaita N, Tongtako W. Methodology: Ittinirundorn S, Wongsaita N. Formal analysis: Ittinirundorn S, Wongsaita N, Tongtako W. Data curation: Ittinirundorn S, Wongsaita N, Somboonviboon D, Tongtako W. Writing - original draft preparation: Ittinirundorn S. Writing - review and editing: Tongtako W. Approval of final manuscript: all authors.
No potential conflict of interest relevant to this article was reported.
This research was supported by the 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund) of Chulalongkorn University and Faculty of Sports Science Fund of Chulalongkorn University.
The authors thank all participants and research assistants for helping and organizing this study. The authors also thank all nurses in Specialty Cline Pulmonary-Allergy & Immunology, Phramongkutklao hospital, Bangkok who provided a place for collecting data and Supranee Buranapraditkun, Ph.D. for cytokines and oxidative stress analysis.
CONSORT 2010 flow diagram showing participant allocation, followup, and analysis.
(A–D) Comparisons of pulmonary function between pre- and post-breathing exercises and between DB and FB groups. Values are presented as mean±SD. *p<0.05 vs. Pre-test. DB: diaphragmatic breathing; FB: Farinelli breathing; SD: standard deviation; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 second; MVV: maximal voluntary.
(A–D) Comparisons of respiratory muscle strength and aerobic capacity between pre- and post-breathing exercise and between DB and FB groups. Values are presented as mean±SD. *p<0.05 vs. Pre-test. †p<0.05 vs. DB group. DB: diaphragmatic breathing; FB: Farinelli breathing; SD: standard deviation; MIP: maximal inspiratory pressure; MEP: maximal expiratory pressure; 6-MWD: 6-minute walk distance; VO2max: maximal oxygen consumption.
Comparisions of inflammatory cytokine (A, TNF-α and B, IL-6) and oxidative stress (MDA) (C) levels between pre- and postbreathing exercise and between DB and FB groups. *p<0.05 vs. Pretest. DB: diaphragmatic breathing; FB: Farinelli breathing; TNF-α: tumor necrosis factor-α; IL-6: interleukin-6; MDA: malondialdehyde.
Comparisions of effects of exercise on COPD symptoms (A, mMRC and B, CAT) between pre- and post-breathing exercise and between DB and FB groups. *p<0.05 vs. Pre-test. COPD: chronic obstructive pulmonary disease; mMRC: modified Medical Research Council; CAT: COPD assessment test; DB: diaphragmatic breathing; FB: Farinelli breathing
Physiological characteristics of subjects in DB and FB groups
Variable | DB (n=8) | FB (n=8) | p-value |
---|---|---|---|
Age, yr | 66.63±9 | 67.63±7.93 | 0.82 |
Male:Female | 7:1 | 7:1 | - |
Weight, kg | 70.78±15.62 | 70.65±14.02 | 0.99 |
RHR, bpm | 83.75±20.23 | 86.00±16.13 | 0.80 |
BMI, kg/m2 | 25.86±5.99 | 26.31±4.21 | 0.86 |
SBP, mm Hg | 116.38±23.31 | 127.88±4.57 | 0.19 |
DBP, mm Hg | 73.50±10.98 | 80.75±4.52 | 0.10 |
PBF, % | 29.69±8.15 | 30.35±7.91 | 0.92 |
SpO2, % | 96.63±1.69 | 95.25±1.98 | 0.16 |
FVC, L | 2.47±0.49 | 2.34±0.69 | 0.68 |
FEV1 predicted, % | 73.36±8.81 | 72.01±11.37 | 0.80 |
FVC predicted, % | 78.38±17.80 | 74.25±20.82 | 0.68 |
Values are presented as mean±SD.
DB: diaphragmatic breathing; FB: Farinelli’s breathing; RHR: resting heart rate; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; PBF: percent of body fat; SpO2: oxygen saturation; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 second.